Chargement en cours...
State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
INTRODUCTION: The extreme health and economic problems in the world due to the SARS-CoV-2 infection have led to an urgent need to identify potential drug targets for treating coronavirus disease 2019 (COVID-19). The present state-of-the-art tool-based screening was targeted to identify drug targets...
Enregistré dans:
| Publié dans: | Arch Med Sci |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Termedia Publishing House
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7212215/ https://ncbi.nlm.nih.gov/pubmed/32399096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2020.94567 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|